Phase 4 COPD Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults between 18 and 65 years old who have been diagnosed with cough-variant asthma (CVA), meaning they have had a persistent cough for 8 weeks or more as their main symptom, tested positive on a specific breathing test called a methacholine challenge, and have a history of their cough improving with asthma treatments such as inhaled steroids or bronchodilators.
- Adults between 18 and 65 years old who have had a persistent cough for 8 weeks or more as their main symptom but tested negative on the methacholine challenge breathing test.
- Adults between 18 and 65 years old with no history of asthma or long-term persistent cough (this group may serve as a comparison group — confirm with trial site).
Who may not be able to join:
- People who have had a worsening of their condition in the past 4 weeks that required a change in medication, a visit to the emergency department, or a hospital stay.
- People who are unable to perform a standard breathing test called spirometry.
- People who have a medical reason they cannot safely undergo methacholine challenge testing (confirm with trial site for specific conditions this covers).
- People who have a significant smoking history of more than 10 pack-years (roughly, smoking one pack of cigarettes per day for more than 10 years, or the equivalent amount over a different time period).
Note: Having previously used inhaled or oral corticosteroid (steroid) medications does not prevent someone from being considered — the trial will record and review medication use as part of the study.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: M. Diane Lougheed, MD, MSc, Department of Medicine, Queen's University
Phone: 613-548-2348
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Mid expiratory flows
Can't join this trial?
Data last synced from ClinicalTrials.gov: 12 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.